ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
60 850,59
0,09%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Immupharma Plc (IMM)

  7. Immupharma Plc (IMM) Actualités

IMM

Immupharma (IMM)

Immupharma Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:IMM
DateHeureSourceTitreSymboleSociété
03/05/202408h00RNS Regulatory NewsImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
24/04/202408h12RNS Non-RegulatoryImmupharma PLC IMMUPHARMA AT BIO-EQUITY 2024 12-14 MayLSE:IMMImmupharma Plc
19/04/202408h00RNS Regulatory NewsImmupharma PLC Grant of Share OptionsLSE:IMMImmupharma Plc
02/04/202413h52Alliance NewsAlliance NewsImmupharma jumps amid new IP strategy for P140 technology platformLSE:IMMImmupharma Plc
02/04/202408h03RNS Regulatory NewsImmupharma PLC New intellectual property strategy initiatedLSE:IMMImmupharma Plc
25/03/202413h20Alliance NewsAlliance NewsIncanthera says first order from skincare deal doublesLSE:IMMImmupharma Plc
25/03/202408h25RNS Regulatory NewsImmupharma PLC Incanthera provides Comm'l Update/Revenue F'castsLSE:IMMImmupharma Plc
14/03/202408h00RNS Non-RegulatoryImmupharma PLC IMMUPHARMA AT BIO-EUROPE SPRING 2024LSE:IMMImmupharma Plc
06/03/202414h05Alliance NewsAlliance NewsEARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue upLSE:IMMImmupharma Plc
06/03/202408h00RNS Regulatory NewsImmupharma PLC Financial, Business and Portfolio Develop't UpdateLSE:IMMImmupharma Plc
19/12/202318h52Alliance NewsAlliance NewsEARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrowsLSE:IMMImmupharma Plc
19/12/202308h00UK RegulatoryImmupharma PLC Simbec-Orion appointed as CROLSE:IMMImmupharma Plc
18/12/202308h15UK RegulatoryImmupharma PLC Incanthera - Comm'l Skincare Deal/GBP1M FundraiseLSE:IMMImmupharma Plc
07/09/202318h07Alliance NewsAlliance NewsTRADING UPDATES: RA International loss narrows as revenue growsLSE:IMMImmupharma Plc
07/09/202308h00UK RegulatoryImmupharma PLC Result of Retail Offer and Director ShareholdingLSE:IMMImmupharma Plc
31/08/202314h05Alliance NewsAlliance NewsImmuPharma launches GBP2 million fund raise as interim loss narrowsLSE:IMMImmupharma Plc
31/08/202308h02UK RegulatoryImmupharma PLC WRAP Retail Offer for up to GBP0.5mLSE:IMMImmupharma Plc
31/08/202308h01UK RegulatoryImmupharma PLC Subscription to raise GBP1.35m; Sharing Agr, RPTLSE:IMMImmupharma Plc
31/08/202308h00UK RegulatoryImmupharma PLC Interim resultsLSE:IMMImmupharma Plc
21/08/202308h00UK RegulatoryImmupharma PLC Extension of warrants in Incanthera plcLSE:IMMImmupharma Plc
11/08/202313h04UK RegulatoryImmupharma PLC Directorate ChangeLSE:IMMImmupharma Plc
30/06/202314h12UK RegulatoryImmupharma PLC Result of AGMLSE:IMMImmupharma Plc
19/06/202313h02Alliance NewsAlliance NewsIN BRIEF: ImmuPharma to start next two phases of Lupuzor trialLSE:IMMImmupharma Plc
19/06/202308h00UK RegulatoryImmupharma PLC Lupuzor UpdateLSE:IMMImmupharma Plc
06/06/202308h00UK RegulatoryImmupharma PLC IMM RNS Posting of RA and Notice of AGM 30 June 23LSE:IMMImmupharma Plc
18/05/202313h12Alliance NewsAlliance NewsIN BRIEF: ImmuPharma rises on FDA feedback for neurological diseaseLSE:IMMImmupharma Plc
18/05/202311h38Dow Jones NewsImmuPharma Shares Rise on Positive Guidance From US FDA for P140LSE:IMMImmupharma Plc
18/05/202308h00UK RegulatoryImmupharma PLC Positive Pre-IND meeting with FDALSE:IMMImmupharma Plc
11/05/202312h48Alliance NewsAlliance NewsIN BRIEF: ImmuPharma annual loss narrows as R&D spending reducedLSE:IMMImmupharma Plc
11/05/202308h00UK RegulatoryImmupharma PLC Final ResultsLSE:IMMImmupharma Plc
 Showing the most relevant articles for your search:LSE:IMM

Dernières Valeurs Consultées

NASDAQ
AMZN
Amazon.com
EU
DG
Vinci
NASDAQ
NVDA
NVIDIA
EU
BN
Danone
NASDAQ
AAPL
Apple
EU
BEL20
Bel 20
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
EU
PX4
SBF 120
NYSE
MCD
McDonalds
EU
CAP
Capgemini
NASDAQ
MSFT
Microsoft
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés